Lumbar functional evaluation of pelvic bone sarcomas after surgical resection and spinal pelvic fixation: A clinical study of 304 cases
- PMID: 38819113
- PMCID: PMC11140840
- DOI: 10.1002/cam4.7282
Lumbar functional evaluation of pelvic bone sarcomas after surgical resection and spinal pelvic fixation: A clinical study of 304 cases
Abstract
Aims: We endeavored to introduce a novel scoring system (Lumbar Functional Index, LFI) capable of evaluating lumbar function in pelvic bone sarcoma patients who underwent surgical resection and spinal pelvic fixation, while simultaneously identifying the incidence, outcomes, and risk factors of lumbar function impairment among these populations.
Patients and methods: A cohort of 304 primary bone sarcoma patients were recruited. The LFI was created based on the Oswestry Dysfunction Index (ODI) and Japanese Orthopaedic Association (JOA) scores. Lumbar function impairment was defined as LFI score ≥ 18 points, which was identified as high LFI. Demographic data, clinical characteristics, and oncological outcomes were analyzed.
Results: The cohort included chondrosarcoma (39.8%), osteosarcoma (29.9%), Ewing sarcoma (8.6%), bone-derived undifferentiated pleomorphic sarcoma (7.2%), giant cell tumor of bone (7.2%), chordoma (2.3%), and other bone sarcomas (5.0%). The LFI score exhibited significant negative correlation with common scoring systems of bone sarcoma. The incidence of high LFI was 23.0%. Patients with high LFI demonstrated a higher prevalence of type I + II + III + IV pelvic tumor, more sacrificed nerve roots and bilateral lumbar spine fixation during surgery, while lower percentage of R0 resection and local control of pelvic tumor. Decreased median overall survival (30 vs. 52 months, p < 0.001) and recurrence-free survival (14 vs. 24 months, p < 0.001) time were observed in these patients. Type I + II + III + IV pelvic tumor and sacrificed nerve roots≥2 were identified as risk factors for high LFI, while R0 resection and local control were identified as protective factors.
Conclusion: The LFI scoring system exhibited a significant negative correlation to current scoring systems. High LFI patients had worse prognosis and distinct characteristics. The risk factors of high LFI included type I + II + III + IV pelvic tumor and sacrificed nerve roots≥2, and the protective factors included R0 resection and local control.
Keywords: bone sarcomas; functional outcomes; lumbar functional index; pelvis; spinal pelvic fixation.
© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no potential conflict of interest.
Figures




Similar articles
-
Resection margins obtained with patient-specific instruments for resecting primary pelvic bone sarcomas: A case-control study.Orthop Traumatol Surg Res. 2019 Jun;105(4):781-787. doi: 10.1016/j.otsr.2018.12.016. Epub 2019 Apr 11. Orthop Traumatol Surg Res. 2019. PMID: 30982774
-
Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.Clin Orthop Relat Res. 2020 Feb;478(2):290-302. doi: 10.1097/CORR.0000000000000962. Clin Orthop Relat Res. 2020. PMID: 31580267 Free PMC article.
-
[Surgical margins as prognostic factor in pelvis chondrosarcoma. Cohort study in a sarcoma unit].Acta Ortop Mex. 2023 Nov-Dec;37(6):331-337. Acta Ortop Mex. 2023. PMID: 38467453 Spanish.
-
Does adding sacroiliac (type IV) resection to periacetabular (type II) resection increase complications or provide worse clinical outcomes? An institutional experience and systematic review.Surg Oncol. 2024 Oct;56:102116. doi: 10.1016/j.suronc.2024.102116. Epub 2024 Aug 8. Surg Oncol. 2024. PMID: 39128439
-
Pelvic bone sarcomas, prognostic factors, and treatment: A narrative review of the literature.Scand J Surg. 2023 Sep;112(3):206-215. doi: 10.1177/14574969231181504. Epub 2023 Jul 12. Scand J Surg. 2023. PMID: 37438963 Review.
References
-
- Parry MC, Laitinen M, Albergo J, et al. Osteosarcoma of the pelvis. Bone Joint J. 2016;98‐B(4):555‐563. - PubMed
-
- Morris CD. Pelvic bone sarcomas: controversies and treatment options. J Natl Compr Cancer Netw. 2010;8(6):731‐737. - PubMed
-
- Lex JR, Kurisunkal V, Kaneuchi Y, et al. Pelvic Ewing sarcoma: should all patients receive pre‐operative radiotherapy, or should it be delivered selectively? Eur J Surg Oncol. 2021;47(10):2618‐2626. - PubMed
-
- Weinschenk RC, Wang WL, Lewis VO. Chondrosarcoma. J Am Acad Orthop Surg. 2021;29(13):553‐562. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical